Hideki Terai

2.3k citations

41 papers · 778 · h-index 15

Impact in

Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Pulmonary and Respiratory Medicine top 10%
- Lung Cancer Treatments and Mutations

Papers in

Pulmonary and Respiratory Medicine 23
- Lung Cancer Treatments and Mutations 21
- Lung Cancer Diagnosis and Treatment 4
Molecular Biology 21
- PI3K/AKT/mTOR signaling in cancer 5
- Epigenetics and DNA Methylation 4

Co-authors: Kenzo Soejima (26 shared papers)Shinnosuke Ikemura (24 shared papers)Katsuhiko Naoki (16 shared papers)Takashi Sato (14 shared papers)Satoshi Yoda (12 shared papers)Sohei Nakayama (13 shared papers)Tomoko Betsuyaku (9 shared papers)Ryosuke Satomi (10 shared papers)
Journals: Molecular Cancer Research (4 papers)Lung Cancer (4 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
Partner nations: Japan United States United Kingdom

In The Last Decade

Hideki Terai

36 papers receiving 772 citations

Peers

Countries citing papers authored by Hideki Terai

Since Specialization

Citations

This map shows the geographic impact of Hideki Terai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Terai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Terai more than expected).

Fields of papers citing papers by Hideki Terai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Terai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Terai. The network helps show where Hideki Terai may publish in the future.

Co-authors

The 25 scholars most cited alongside Hideki Terai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hideki Terai Line = papers co-authored together Hideki Terai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC Molecular Cancer Research ·Hideki Terai, Kenzo Soejima, Hiroyuki Yasuda, Sohei Nakayama, Junko Hamamoto, Daisuke Arai, Kota Ishioka, Keiko Ohgino, Shinnosuke Ikemura, Takashi Sato, Satoshi Yoda, Ryosuke Satomi, Katsuhiko Naoki, Tomoko Betsuyaku	2013	174
2	Overcoming Resistance to the THZ Series of Covalent Transcriptional CDK Inhibitors Cell chemical biology ·Yang Gao, Tinghu Zhang, Hideki Terai, Scott B. Ficarro, Nicholas Kwiatkowski, Ming-Feng Hao, Bandana Sharma, Camilla L. Christensen, Edmond Chipumuro, Kwok‐Kin Wong, Jarrod A. Marto, Peter S. Hammerman, Nathanael S. Gray, Rani E. George	2017	56
3	Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma Molecular Medicine Reports ·Junko Hamamoto, Kenzo Soejima, Satoshi Yoda, Katsuhiko Naoki, Sohei Nakayama, Ryosuke Satomi, Hideki Terai, Shinnosuke Ikemura, Takashi Sato, Hiroyuki Yasuda, Yuichiro Hayashi, Michiie Sakamoto, Toru Takebayashi, Tomoko Betsuyaku	2013	54
4	Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer ACS Chemical Biology ·Hideki Terai, Li Tan, Ellen M. Beauchamp, John M. Hatcher, Qingsong Liu, Matthew Meyerson, Nathanael S. Gray, Peter S. Hammerman	2015	43
5	Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer Lung Cancer ·Keiko Ohgino, Kenzo Soejima, Hiroyuki Yasuda, Yuichiro Hayashi, Junko Hamamoto, Katsuhiko Naoki, Daisuke Arai, Kota Ishioka, Takashi Sato, Hideki Terai, Shinnosuke Ikemura, Satoshi Yoda, Tetsuo Tani, Aoi Kuroda, Tomoko Betsuyaku	2013	41
6	Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations Lung Cancer ·Hanako Hasegawa, Hiroyuki Yasuda, Junko Hamamoto, Keita Masuzawa, Tetsuo Tani, Shigenari Nukaga, Toshiyuki Hirano, Keigo Kobayashi, Tadashi Manabe, Hideki Terai, Shinnosuke Ikemura, Ichiro Kawada, Katsuhiko Naoki, Kenzo Soejima	2018	40
7	IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer Molecular Cancer Research ·Tadashi Manabe, Hiroyuki Yasuda, Hideki Terai, Harumi Kagiwada, Junko Hamamoto, Toshiki Ebisudani, Keigo Kobayashi, Keita Masuzawa, Shinnosuke Ikemura, Ichiro Kawada, Yuichiro Hayashi, Kazuhiko Fukui, Katsuhisa Horimoto, Koichi Fukunaga, Kenzo Soejima	2020	39
8	The PCR-invader method (structure-specific 5′ nuclease-based method), a sensitive method for detecting EGFR gene mutations in lung cancer specimens; comparison with direct sequencing International Journal of Clinical Oncology ·Katsuhiko Naoki, Kenzo Soejima, Hiroaki Okamoto, Junko Hamamoto, Naoya Hida, Ichiro Nakachi, Hiroyuki Yasuda, Sohei Nakayama, Satoshi Yoda, Ryosuke Satomi, Shinnosuke Ikemura, Hideki Terai, Takashi Sato, Koshiro Watanabe	2011	39
9	Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer Lung Cancer ·Satoshi Yoda, Kenzo Soejima, Junko Hamamoto, Hiroyuki Yasuda, Sohei Nakayama, Ryosuke Satomi, Hideki Terai, Shinnosuke Ikemura, Takashi Sato, Katsuhiko Naoki, Tomoko Betsuyaku	2014	38
10	FOXD1 expression is associated with poor prognosis in non-small cell lung cancer. PubMed ·Sohei Nakayama, Kenzo Soejima, Hiroyuki Yasuda, Satoshi Yoda, Ryosuke Satomi, Shinnosuke Ikemura, Hideki Terai, Takashi Sato, Norihiro Yamaguchi, Junko Hamamoto, Daisuke Arai, Kota Ishioka, Keiko Ohgino, Katsuhiko Naoki, Tomoko Betsuyaku	2015	35
11	The reasons for triple therapy in stable COPD patients in Japanese clinical practice International Journal of COPD ·Hidetoshi Nakamura, Masaki Miyazaki, Saeko Takahashi, Shotaro Chubachi, Mamoru Sasaki, Mizuha Haraguchi, Hideki Terai, Makoto Ishii, Koichi Fukunaga, Sadatomo Tasaka, Kenzo Soejima, Koichiro Asano, Tomoko Betsuyaku	2015	26
12	NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination Therapy Molecular Cancer Therapeutics ·Chunxiao Xu, Kevin A. Buczkowski, Yanxi Zhang, Hajime Asahina, Ellen M. Beauchamp, Hideki Terai, Yvonne Y. Li, Matthew Meyerson, Kwok‐Kin Wong, Peter S. Hammerman	2015	24
13	The Combination of Multiple Receptor Tyrosine Kinase Inhibitor and Mammalian Target of Rapamycin Inhibitor Overcomes Erlotinib Resistance in Lung Cancer Cell Lines through c-Met Inhibition Molecular Cancer Research ·Ichiro Nakachi, Katsuhiko Naoki, Kenzo Soejima, Ichiro Kawada, Hideo Watanabe, Hiroyuki Yasuda, Sohei Nakayama, Satoshi Yoda, Ryosuke Satomi, Shinnosuke Ikemura, Hideki Terai, Takashi Sato, Akitoshi Ishizaka	2010	24
14	Bronchoscopic Microsampling is a Useful Complementary Diagnostic Tool for Detecting Lung Cancer Lung Cancer ·Hiroyuki Yasuda, Kenzo Soejima, Sohei Nakayama, Ichiro Kawada, Ichiro Nakachi, Satoshi Yoda, Ryosuke Satomi, Shinnosuke Ikemura, Hideki Terai, Takashi Sato, Hideo Watanabe, Katsuhiko Naoki, Yuichiro Hayashi, Akitoshi Ishizaka	2010	17
15	Methylation‐induced downregulation of TFPI‐2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non‐small‐cell lung carcinoma Cancer Science ·Junko Hamamoto, Kenzo Soejima, Katsuhiko Naoki, Hiroyuki Yasuda, Yuichiro Hayashi, Satoshi Yoda, Sohei Nakayama, Ryosuke Satomi, Hideki Terai, Shinnosuke Ikemura, Takashi Sato, Daisuke Arai, Kota Ishioka, Keiko Ohgino, Tomoko Betsuyaku	2014	17
16	SHOC2 Is a Critical Modulator of Sensitivity to EGFR–TKIs in Non–Small Cell Lung Cancer Cells Molecular Cancer Research ·Hideki Terai, Junko Hamamoto, Katsura Emoto, Takeshi Masuda, Tadashi Manabe, Satoshi Kuronuma, Keigo Kobayashi, Keita Masuzawa, Shinnosuke Ikemura, Sohei Nakayama, Ichiro Kawada, Yusuke Suzuki, Osamu Takeuchi, Yukio Suzuki, Sumio Ohtsuki, Hiroyuki Yasuda, Kenzo Soejima, Koichi Fukunaga	2020	13
17	Long-term exposure to gefitinib induces acquired resistance through DNA methylation changes in the EGFR-mutant PC9 lung cancer cell line International Journal of Oncology ·Hideki Terai, Kenzo Soejima, Hiroyuki Yasuda, Takashi Sato, Katsuhiko Naoki, Shinnosuke Ikemura, Daisuke Arai, Keiko Ohgino, Kota Ishioka, Junko Hamamoto, Yae Kanai, Tomoko Betsuyaku	2014	12
18	Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis The Oncologist ·Kohei Horiuchi, Shinnosuke Ikemura, Takashi Sato, Keitaro Shimozaki, Satoshi Okamori, Yoshitake Yamada, Yoichi Yokoyama, Masahiro Hashimoto, Masahiro Jinzaki, Ikuko Hirai, Takeru Funakoshi, Ryuichi Mizuno, Mototsugu Oya, Kenro Hirata, Yasuo Hamamoto, Hideki Terai, Hiroyuki Yasuda, Ichiro Kawada, Kenzo Soejima, Koichi Fukunaga	2023	12
19	Clinical Efficacy and Future Prospects of Immunotherapy in Lung Cancer Life ·Tomonari Kinoshita, Hideki Terai, Tomonori Yaguchi	2021	11
20	Increased DNA-incorporated thiopurine metabolite as a possible mechanism for leukocytopenia through cell apoptosis in inflammatory bowel disease patients with NUDT15 mutation Journal of Gastroenterology ·Takahiko Toyonaga, Taku Kobayashi, Satoshi Kuronuma, Aito Ueno, Hiroki Kiyohara, Shinji Okabayashi, Osamu Takeuchi, Christopher P.F. Redfern, Hideki Terai, Ryo Ozaki, Shintaro Sagami, Masaru Nakano, Sally A. Coulthard, Yoïchi Tanaka, Toshifumi Hibi∥	2021	10

About Hideki Terai

Hideki Terai is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Immunology, having authored 41 papers that have together received 778 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Genomics and Diagnostics (4 papers), Epigenetics and DNA Methylation (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Cancer Research (199 citations), Pulmonary and Respiratory Medicine (358 citations), Oncology (297 citations), Molecular Biology (480 citations) and Immunology and Allergy (29 citations). Hideki Terai has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kenzo Soejima, Shinnosuke Ikemura, Katsuhiko Naoki, Takashi Sato, Satoshi Yoda, Sohei Nakayama, Tomoko Betsuyaku, Ryosuke Satomi, Hiroyuki Yasuda and Junko Hamamoto. Their work appears in journals such as Molecular Cancer Research, Lung Cancer, Cancer Research, Molecular Cancer Therapeutics and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Hideki Terai

Impact in

Papers in i

In The Last Decade

Hideki Terai

Peers

Countries citing papers authored by Hideki Terai

Fields of papers citing papers by Hideki Terai

All Works

About Hideki Terai

Explore authors with similar magnitude of impact

Papers in